<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8" /><meta http-equiv="Content-Language" content="en" /><title>Verbatim report of proceedings - Discharge 2013: European Medicines Agency (EMA) (A8-0075/2015 - Ryszard Czarnecki) - Wednesday, 29 April 2015</title><meta name="title" content="Verbatim report of proceedings - Discharge 2013: European Medicines Agency (EMA) (A8-0075/2015 - Ryszard Czarnecki) - Wednesday, 29 April 2015" /><meta name="language" content="en" /><meta name="robots" content="index, follow, noodp, noydir, notranslate" /><meta name="copyright" content="© European Union, 2015 - Source: European Parliament" /><meta name="available" content="29-04-2015" /><meta name="sipade-leg" content="8" /><meta name="sipade-type" content="CRE" /><meta property="og:title" content="Verbatim report of proceedings - Discharge 2013: European Medicines Agency (EMA) (A8-0075/2015 - Ryszard Czarnecki) - Wednesday, 29 April 2015" /><meta property="og:image" content="https://www.europarl.europa.eu/website/common/img/icon/sharelogo_facebook.jpg" /><link rel="canonical" href="https://www.europarl.europa.eu/doceo/document/CRE-8-2015-04-29-ITM-011-38_EN.html" /><link href="/doceo/data/css/style_common.css" rel="stylesheet" type="text/css" /><link href="/doceo/data/css/style_common_print.css" rel="stylesheet" type="text/css" /><link href="/doceo/data/css/style_sipade.css" rel="stylesheet" type="text/css" /><link href="/doceo/data/css/style_activities.css" rel="stylesheet" type="text/css" /><link href="/doceo/data/css/common_sides.css" type="text/css" rel="stylesheet" /><link href="/doceo/data/css/style_sipade_oj_sched.css" type="text/css" rel="stylesheet" />
<script src="/doceo/data/js/overlib.js" type="text/javascript"> </script>
<script src="/doceo/data/js/swap_images.js" type="text/javascript"> </script>
<script src="/doceo/data/js/sipade.js" type="text/javascript"> </script>
<script src="/doceo/data/js/jquery-1.4.4.js" type="text/javascript"> </script>
<script src="/doceo/data/js/sipade-OJ-SYN.js" type="text/javascript"> </script><!--ATI analytics script--><script type="text/javascript" data-tracker-name="ATInternet" defer data-value="/website/webanalytics/ati-doceo.js" src="//www.europarl.europa.eu/website/privacy-policy/privacy-policy.js" ></script></head><body bgcolor="#FFFFFF"><div id="overDiv" style="position:absolute; visibility:hidden; z-index:1000;"> </div><a name="top"></a><table cellpadding="0" cellspacing="0" border="0" width="100%"><tr><td><div id="header_sides" class="new">
<a href="/portal/en"><img alt="Go back to the Europarl portal" title="Go back to the Europarl portal" src="/doceo/data/img/EP_logo_neg_EN.png" /></a><h3 class="ep_hidden">Choisissez la langue de votre document :</h3><ul class="language_select">
            <li><a title="bg - български" class="bg on" href="/doceo/document/CRE-8-2015-04-29-ITM-011-38_BG.html">bg - български</a></li>
            <li><a title="es - español" class="es on" href="/doceo/document/CRE-8-2015-04-29-ITM-011-38_ES.html">es - español</a></li>
            <li><a title="cs - čeština" class="cs on" href="/doceo/document/CRE-8-2015-04-29-ITM-011-38_CS.html">cs - čeština</a></li>
            <li><a title="da - dansk" class="da on" href="/doceo/document/CRE-8-2015-04-29-ITM-011-38_DA.html">da - dansk</a></li>
            <li><a title="de - Deutsch" class="de on" href="/doceo/document/CRE-8-2015-04-29-ITM-011-38_DE.html">de - Deutsch</a></li>
            <li><a title="et - eesti keel" class="et on" href="/doceo/document/CRE-8-2015-04-29-ITM-011-38_ET.html">et - eesti keel</a></li>
            <li><a title="el - ελληνικά" class="el on" href="/doceo/document/CRE-8-2015-04-29-ITM-011-38_EL.html">el - ελληνικά</a></li>
            <li class="en selected" title="en - English">en - English<span> (Selected)</span></li>
            <li><a title="fr - français" class="fr on" href="/doceo/document/CRE-8-2015-04-29-ITM-011-38_FR.html">fr - français</a></li>
            <li class="ga" title="ga - Gaeilge">ga - Gaeilge</li>
            <li><a title="hr - hrvatski" class="hr on" href="/doceo/document/CRE-8-2015-04-29-ITM-011-38_HR.html">hr - hrvatski</a></li>
            <li><a title="it - italiano" class="it on" href="/doceo/document/CRE-8-2015-04-29-ITM-011-38_IT.html">it - italiano</a></li>
            <li><a title="lv - latviešu valoda" class="lv on" href="/doceo/document/CRE-8-2015-04-29-ITM-011-38_LV.html">lv - latviešu valoda</a></li>
            <li><a title="lt - lietuvių kalba" class="lt on" href="/doceo/document/CRE-8-2015-04-29-ITM-011-38_LT.html">lt - lietuvių kalba</a></li>
            <li><a title="hu - magyar" class="hu on" href="/doceo/document/CRE-8-2015-04-29-ITM-011-38_HU.html">hu - magyar</a></li>
            <li><a title="mt - Malti" class="mt on" href="/doceo/document/CRE-8-2015-04-29-ITM-011-38_MT.html">mt - Malti</a></li>
            <li><a title="nl - Nederlands" class="nl on" href="/doceo/document/CRE-8-2015-04-29-ITM-011-38_NL.html">nl - Nederlands</a></li>
            <li><a title="pl - polski" class="pl on" href="/doceo/document/CRE-8-2015-04-29-ITM-011-38_PL.html">pl - polski</a></li>
            <li><a title="pt - português" class="pt on" href="/doceo/document/CRE-8-2015-04-29-ITM-011-38_PT.html">pt - português</a></li>
            <li><a title="ro - română" class="ro on" href="/doceo/document/CRE-8-2015-04-29-ITM-011-38_RO.html">ro - română</a></li>
            <li><a title="sk - slovenčina" class="sk on" href="/doceo/document/CRE-8-2015-04-29-ITM-011-38_SK.html">sk - slovenčina</a></li>
            <li><a title="sl - slovenščina" class="sl on" href="/doceo/document/CRE-8-2015-04-29-ITM-011-38_SL.html">sl - slovenščina</a></li>
            <li><a title="fi - suomi" class="fi on" href="/doceo/document/CRE-8-2015-04-29-ITM-011-38_FI.html">fi - suomi</a></li>
            <li><a title="sv - svenska" class="sv on" href="/doceo/document/CRE-8-2015-04-29-ITM-011-38_SV.html">sv - svenska</a></li>
        </ul></div></td></tr><tr><td style="padding:10px;"><table width="100%" border="0" cellspacing="0" cellpadding="0"><tr><td><table border="0" align="left" cellpadding="0" cellspacing="0"><tr><td><table border="0" cellspacing="0" cellpadding="0" class="buttondocwin"><tr><td><a href="/doceo/document/CRE-8-2015-04-29-TOC_EN.html"><img src="/doceo/data/img/navi_index.gif" width="16" height="16" border="0" align="absmiddle" alt="" /></a></td><td valign="middle"> <a href="/doceo/document/CRE-8-2015-04-29-TOC_EN.html" title="Index">Index</a> </td></tr></table></td><td><img src="/doceo/data/img/spacer.gif" width="10" height="8" alt="" /></td><td><table border="0" cellspacing="0" cellpadding="0" class="buttondocwin"><tr><td><a href="/doceo/document/CRE-8-2015-04-29-ITM-011-37_EN.html"><img src="/doceo/data/img/navi_previous.gif" width="16" height="16" border="0" align="absmiddle" alt="" /></a></td><td valign="middle"> <a href="/doceo/document/CRE-8-2015-04-29-ITM-011-37_EN.html" title="Previous">Previous</a> </td></tr></table></td><td><img src="/doceo/data/img/spacer.gif" width="10" height="8" alt="" /></td><td><table border="0" cellspacing="0" cellpadding="0" class="buttondocwin"><tr><td valign="middle"> <a href="/doceo/document/CRE-8-2015-04-29-ITM-011-39_EN.html" title="Next">Next</a> </td><td><a href="/doceo/document/CRE-8-2015-04-29-ITM-011-39_EN.html"><img src="/doceo/data/img/navi_next.gif" width="16" height="16" border="0" align="absmiddle" alt="" /></a></td></tr></table></td><td><img src="/doceo/data/img/spacer.gif" width="10" height="8" alt="" /></td><td><table border="0" cellspacing="0" cellpadding="0" class="buttondocwin"><tr><td><a href="/doceo/document/CRE-8-2015-04-29_EN.html"><img src="/doceo/data/img/navi_moredetails.gif" width="16" height="16" border="0" align="absmiddle" alt="" /></a></td><td valign="middle"> <a href="/doceo/document/CRE-8-2015-04-29_EN.html" title="Full text">Full text</a> </td></tr></table></td><td><img src="/doceo/data/img/spacer.gif" width="10" height="8" alt="" /></td></tr><tr><td><img src="/doceo/data/img/spacer.gif" width="10" height="15" alt="" /></td></tr></table></td></tr></table>
                <table border="0" cellpadding="0" cellspacing="0" width="100%"><tbody><tr><td align="left"><span class="contents">Procedure : </span><a class="ring_ref_link" href="https://oeil.secure.europarl.europa.eu/oeil/popups/ficheprocedure.do?lang=en&amp;reference=2014/2102(DEC)">2014/2102(DEC)</a></td><td align="right"><table align="right" border="0" cellpadding="0" cellspacing="0"><tbody><tr><td><img src="/doceo/data/img/ring_tabs_left_doc_unselected.gif" height="19" width="4" alt="" /></td><td class="Tabs_doc_unselected"><img src="/doceo/data/img/ring_navi.gif" width="17" height="14" alt="" />Document stages in plenary</td><td valign="middle"><img src="/doceo/data/img/ring_tabs_right_doc_unselected.gif" height="19" width="4" alt="" /></td></tr></tbody></table></td></tr></tbody></table><table class="doc_box_header" border="0" cellpadding="0" cellspacing="0" width="100%"><tbody><tr><td class="ring_multiple_bg" valign="top" colspan="7">Document selected :
            <span class="ring_ref_selected_header">A8-0075/2015</span></td></tr><tr><td width="25%" valign="top" class="ring_step_bg1" nowrap="nowrap"><p class="ring_step_title">Texts tabled :</p>
                        <a href="/doceo/document/A-8-2015-0075_EN.html" class="ring_ref_link">A8-0075/2015</a><br />
                    </td><td width="15" style="background-image:url(/doceo/data/img/ring_bg1.gif)"><img src="/doceo/data/img/ring_flech1.gif" height="22" width="13" border="0" alt="" /></td><td class="ring_step_bg2" valign="top" width="25%" nowrap="nowrap"><p class="ring_step_title">Debates :</p>
                        <a href="/doceo/document/PV-8-2015-04-28-ITM-016_EN.html" class="ring_ref_link">PV 28/04/2015 - 16</a><br />
                        <a href="/doceo/document/CRE-8-2015-04-28-ITM-016_EN.html" class="ring_ref_link">CRE 28/04/2015 - 16</a><br />
                    </td><td width="15" style="background-image:url(/doceo/data/img/ring_bg2.gif)"><img src="/doceo/data/img/ring_flech2.gif" width="13" height="22" border="0" alt="" /></td><td class="ring_step_bg3" valign="top" width="25%" nowrap="nowrap"><p class="ring_step_title">Votes :</p>
                        <a href="/doceo/document/PV-8-2015-04-29-ITM-010-38_EN.html" class="ring_ref_link">PV 29/04/2015 - 10.38</a><br />
                        <a class="ring_ref_selected">Explanations of votes</a><br />
                    </td><td width="19" style="background-image:url(/doceo/data/img/ring_bg3.gif)"><img src="/doceo/data/img/ring_flech3.gif" height="22" width="13" border="0" alt="" /></td><td class="ring_step_bg4" valign="top" width="25%" nowrap="nowrap"><p class="ring_step_title">Texts adopted :</p>
                        <a href="/doceo/document/TA-8-2015-0147_EN.html" class="ring_ref_link">P8_TA(2015)0147</a><br />
                    </td></tr></tbody></table><br />
            <table width="100%" border="0" cellpadding="5" cellspacing="0" class="doc_box_header">
<tr>
<td align="left" valign="top" style="background-image:url(/doceo/data/img/gradient_blue.gif)" class="title_TA">Verbatim report of proceedings</td><td valign="top" align="right" style="background-image:url(/doceo/data/img/gradient_blue.gif)"></td>
</tr>
<tr>
<td class="doc_title" align="left" valign="top" bgcolor="#F5F5F5">Wednesday, 29 April 2015 - Strasbourg</td>
<td class="doc_title" align="right" valign="top" bgcolor="#F5F5F5">Revised edition</td></tr></table><br />
<table width="100%" border="0" cellpadding="0" cellspacing="0" class="doc_box_header" style="padding-bottom:5px"><tr valign="top"><td>
<table width="100%" border="0" cellpadding="5" cellspacing="0"><tr valign="top" style="padding-bottom:0px;padding-left:5px;padding-right:5px;padding-top:5px"><td align="left" style="background-image:url(/doceo/data/img/gradient_blue.gif)" class="doc_title"><img src="/doceo/data/img/arrow_title_doc.gif" width="8" height="14" border="0" align="absmiddle" alt="" /> 11.38. Discharge 2013: European Medicines Agency (EMA) (<a href="/doceo/document/A-8-2015-0075_EN.html">A8-0075/2015</a> - Ryszard Czarnecki)</td></tr></table>
<a name="3-836-000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/2187.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"></span>  <span class="bold">Dichiarazioni di voto scritte</span></p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-836-007"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/125048.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Marina Albiol Guzmán (GUE/NGL), </span></span>  <span class="italic">por escrito. ‒ </span>Según los Tratados, el Parlamento Europeo tiene el derecho de escrutinio sobre la legalidad y la regularidad de la ejecución de los gastos de las instituciones y agencias europeas cada año. El principal objetivo del ejercicio de este derecho es el de asegurar que los fondos públicos se utilizan de la mejor manera posible. Este escrutinio se basa en el informe del Tribunal de cuentas Europeo, en un procedimiento escrito de preguntas y respuestas, y por último en las audiencias públicas de las instituciones y agencias frente el Parlamento Europeo.</p>
<p class="contents">El Parlamento no ha detectado ninguna irregularidad en la ejecución del presupuesto de la Agencia Europea de Medicamentos (EMA), por eso he votado a favor de aprobar la gestión del mismo.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-836-008"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/125110.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Νίκος Ανδρουλάκης (S&amp;D), </span></span>  <span class="italic">γραπτώς. ‒ </span>Συμφωνώ με την πρόταση της Επιτροπής Προϋπολογισμού του Ευρωπαϊκού Κοινοβουλίου να δώσει απαλλαγή όσον αφορά την εκτέλεση του προϋπολογισμού του Ευρωπαϊκού Οργανισμού Φαρμάκων για το οικονομικό έτος 2013</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-836-004"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124748.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Marie-Christine Arnautu (NI),</span></span>   <span class="italic">par écrit</span><span class="bold">. –</span> Le budget définitif de l'Agence européenne des médicaments pour l'exercice 2013 était de 251 560 000 EUR, soit une hausse de 13,07 % par rapport à 2012. La cour fait observer que 83 % du budget de l'Agence provient des redevances versées par les entreprises du secteur, ce qui représente une augmentation progressive.</p>
<p class="contents">Il n'y a d'ailleurs pas de transparence totale sur cet aspect du budget, il faudrait donc impérativement améliorer ce point afin d'éviter tout risque pour les droits des consommateurs ou la réputation de l'Agence.</p>
<p class="contents">J'ai préféré m'abstenir sur cette décharge.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-836-003"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124958.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Jonathan Arnott (EFDD), </span></span>  <span class="italic">in writing. ‒ </span>The UKIP position, as on all of the votes on the discharge for 2013, was to vote against the granting of discharge. As a Party opposed to the UK's membership of the European Union, which has raised concerns over the spending of taxpayers' money, the Party felt that to do anything other than vote against discharge would send out completely the wrong message to the constituents we were elected to represent. </p>
<p class="contents">I therefore voted against the granting of discharge.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-836-005"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124773.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Jean Arthuis (ALDE), </span></span>  <span class="italic">par écrit. ‒ </span>J'ai donné quitus à cette institution car son focntionnement ne semblait selon l'avis de la commission de contrôle budgétaire contrevenir aux grands principes de bonne gestion de finances publiques. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-836-006"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96680.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Zigmantas Balčytis (S&amp;D), </span></span>  <span class="italic">raštu. ‒ </span>Balsavau už 2013 m. biudžeto įvykdymo ataskaitos patvirtinimą Europos vaistų agentūrai ( toliau- EMA).Audito Rūmai savo ataskaitoje dėl EMA 2013 m. finansinių ataskaitų (toliau – Audito Rūmų ataskaita) pareiškė, kad jie gavo pakankamą patikinimą, jog EMA metinės finansinės ataskaitos yra patikimos ir kad jose atspindimos operacijos yra teisėtos ir tvarkingos, todėl nėra priežasčių nesuteikti biudžeto įvykdymo patvirtinimo už 2013 m. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-836-010"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124760.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Nicolas Bay (NI), </span></span>  <span class="italic">par écrit. ‒ </span>Je me suis abstenu car la transparence de ne me paraît pas suffisante sur certains aspects du budget.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-836-002"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/125002.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Hugues Bayet (S&amp;D), </span></span>  <span class="italic">par écrit. ‒ </span>La Cour des comptes affirme avoir obtenu des assurances raisonnables que les comptes annuels de l'Agence étaient fiables et que les transactions sous-jacentes étaient légales et régulières.</p>
<p class="contents">La résolution rappelle le rôle essentiel joué par l'Agence dans la protection et la promotion de la santé publique et animale par l'évaluation et la surveillance des médicaments à usage humain et vétérinaire</p>
<p class="contents">Elle reconnait, au bénéfice de l'Agence, que les critères de transparence pour les organisations de partenaires, de patients, du secteur des soins de santé et les organisations de consommateurs ont été révisés en 2014 afin d'accroitre la transparence du financement.</p>
<p class="contents">J'ai approuvé la décharge.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-836-009"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124771.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Dominique Bilde (NI), </span></span>  <span class="italic">par écrit. ‒ </span>Le budget définitif de l'Agence pour l'exercice 2013 était de 251,56 millions EUR, soit une hausse de 13,07% par rapport à 2012 dont la part de l’Union européenne se monte à 40.937.951 EUR. Le taux d'exécution budgétaire est de 96,76% pour les engagements et de 83,49% pour les crédits de paiements. La cour fait observer que 83 % du budget de l'Agence provient des redevances versées par les entreprises du secteur mais il n'y a pas d'ailleurs pas de transparence totale sur cet aspect du budget. Je me suis abstenue sur cette décharge. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-836-001"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/97198.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Mara Bizzotto (NI), </span></span>  <span class="italic">per iscritto. ‒ </span>Non condivido le posizioni sostenute nella Relazione oggetto di voto per cui non ho sostenuto contro la concessione del discarico.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-836-250"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/125044.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">José Blanco López (S&amp;D), </span></span>  <span class="italic">por escrito. ‒ </span>He apoyado este informe dado que el Tribunal de Cuentas ha observado cómo se han implementado mejoras respecto a observaciones realizadas en ejercicios precedentes. Hay que destacar que los esfuerzos de supervisión del presupuesto durante el ejercicio 2013 dieron lugar a un porcentaje de ejecución presupuestaria del 96,76 % mientras que la tasa de ejecución de los créditos de pago alcanzó el 83,49 %.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-836-500"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96681.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Vilija Blinkevičiūtė (S&amp;D), </span></span>  <span class="italic">raštu. ‒ </span>Balsavau dėl šio pranešimo, nes juo Europos Parlamentas patvirtina Europos vaistų agentūros vykdomajam direktoriui, kad Agentūros 2013 finansinių metų biudžetas įvykdytas. Parlamentas palankiai įvertino tai, kad siekdama pagerinti ryšius su Sąjungos piliečiais Agentūra neseniai įgyvendino keletą iniciatyvų, pvz., pradėjo skelbti strateginius dokumentus, įskaitant apžvalgas visuomenei, posėdžių santraukas, naujienlaiškius ir metines ataskaitas. Taip pat atkreipia dėmesį, kad buvo parengta IT komunikacijos priemonė „Public health communication“, teikianti visuomenei pagrindinę informaciją apie vaistus, daugiausia apie jų saugumą. Atsižvelgdamas į tai, paskatino Agentūrą surengti viešus klausymus farmakologinio budrumo tema.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-836-750"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/28346.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Mercedes Bresso (S&amp;D), </span></span>  <span class="italic">in writing. ‒ </span>I voted in favour of this resolution because EMA implemented its budget for the financial year 2013 without major errors.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-837-000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124869.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Gianluca Buonanno (NI), </span></span>  <span class="italic">per iscritto. ‒ </span>Il testo chiede la concessione del discarico, di conseguenza il mio voto è stato negativo. I costi della burocrazia europea sono troppo alti e non giustificabili.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-837-005"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124851.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Nicola Caputo (S&amp;D), </span></span>  <span class="italic">per iscritto. ‒ </span>Oggi ho votato a favore della relazione sul discarico per l'esecuzione del bilancio dell'Agenzia europea per i medicinali per l'esercizio 2013.</p>
<p class="contents">Constatato che i conti annuali definitivi dell'Agenzia europea per i medicinali si presentano quali figuranti in allegato alla relazione della Corte dei conti, ho approvato la concessione del discarico al direttore dell'Agenzia europea per i medicinali sulla base delle seguenti considerazioni:</p>
<p class="contents">- sulla gestione finanziaria e di bilancio, osservo che gli sforzi in materia di controllo di bilancio intrapresi durante l'esercizio 2013 hanno avuto come risultato un tasso di esecuzione del bilancio del 96,76%, e che il tasso di esecuzione degli stanziamenti di pagamento è stato dell'83,49%; </p>
<p class="contents">- sulle procedure di appalto e di assunzione, apprendo dall'Agenzia che, in seguito a una gara di appalto, nel 2013 sono stati conclusi 30 nuovi contratti di appalto, ciascuno di importo superiore a 25 000 EUR, rispetto ai 43 del 2012 e ai 28 del 2011; </p>
<p class="contents">- sull’audit interno apprendo che nel 2013 il servizio di audit interno (IAS) della Commissione ha svolto un'attività di consulenza e un'attività di follow-up a norma del suo piano di audit strategico per l'Agenzia per il periodo 2012-2014 concernente la gestione e la comunicazione delle parti.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-837-006"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124752.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Aymeric Chauprade (NI), </span></span>  <span class="italic">par écrit. ‒ </span>J'ai choisi de m'abstenir sur ce rapport qui concerne la décharge sur l'exécution du budget de l'Agence européenne des médicaments pour l'exercice 2013. Il convient en effet de souligner que le budget définitif pour 2013 a subi une hausse de 13.07% par rapport à 2012 et que 83% du budget de l'EMA provient des redevances versées par les entreprises du secteur.</p>
<p class="contents">Cependant, l'audit annuel de la Cour des Comptes n'a relevé aucun problème notable en ce qui concerne le taux de report des crédits en 2013, d'où le fait que je ne me sois pas opposé formellement à la décharge.</p>
<p class="contents">À noter tout de même un certain manque de transparence qu'il faudra surveiller afin de protéger les droits des consommateurs. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-837-003"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124854.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Salvatore Cicu (PPE), </span></span>  <span class="italic">per iscritto. ‒ </span>Considerando che la Corte dei conti, nella sua relazione sui conti annuali dell'Agenzia europea per i medicinali (EMA) relativi all'esercizio 2013, ha dichiarato di aver ottenuto garanzie ragionevoli in merito all'affidabilità dei conti annuali nonché alla legittimità e alla regolarità delle relative operazioni, ho espresso voto favorevole alla concessione del discarico per l'EMA.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-837-004"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124772.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Alberto Cirio (PPE), </span></span>  <span class="italic">per iscritto. ‒ </span>Ho votato a favore del discarico al bilancio dell'Agenzia europea per i medicinali tenuto conto della relazione della Corte dei Conti che attesta l'affidabilità dei conteggi, nonchè la legittimità e la regolarità delle relative operazioni, la raccomandazione del Consiglio che si è espresso in tal senso e il parere della Commissione per l'ambiente, la sanità pubblica e la sicurezza alimentare. Credo che l'Agenzia abbia svolto correttamente il suo ruolo di coordinazione delle risorse scientifiche messe a disposizione dalle autorità nazionali per provvedere alla valutazione e alla vigilanza sui medicinali per uso umano e veterinario. </p>
<p class="contents">Tra l'altro mi sto occupando, in qualità di relatore ombra, del regolamento che modifica l'atto istitutivo di questa agenzia e sto notando quali e quanti delicati compiti essa svolga adeguatamente. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-837-002"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96775.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Lara Comi (PPE), </span></span>  <span class="italic">per iscritto. ‒ </span>Accogliendo con favore l'impegno dell'Agenzia europea per i medicinali per garantire maggiore trasparenza nella gestione finanziaria e bilancio, ho deciso di esprimere il mio voto favorevole alla procedura di discarico per l'esecuzione di bilancio dell'EMA per l'esercizio del 2013.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-837-001"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124856.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Ignazio Corrao (EFDD), </span></span>  <span class="italic">per iscritto. ‒ </span>voto in maniera contraria alla concessione del discarico per il European Medicines Agency (EMA) per problemi di trasparenza dati, conflitti di interessi, debolezze nelle procedure di appalto e nelle procedure di pagamento. Inoltre, esistono duplicazioni e sovrapposizioni di compiti con altre agenzie che andrebbero evitati. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-837-250"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/125997.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Javier Couso Permuy (GUE/NGL), </span></span>  <span class="italic">por escrito. ‒ </span>Según los Tratados, el Parlamento Europeo tiene el derecho de escrutinio sobre la legalidad y la regularidad de la ejecución de los gastos de las instituciones y agencias europeas cada año. El principal objetivo del ejercicio de este derecho es el de asegurar que los fondos públicos se utilizan de la mejor manera posible. Este escrutinio se basa en el informe del Tribunal de cuentas Europeo, en un procedimiento escrito de preguntas y respuestas, y por último en las audiencias públicas de las instituciones y agencias frente el Parlamento Europeo.</p>
<p class="contents">El Parlamento no ha detectado ninguna irregularidad en la ejecución del presupuesto de la Agencia Europea de Medicamentos (EMA), por eso he votado a favor de aprobar la gestión del mismo.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-837-500"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124970.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Miriam Dalli (S&amp;D), </span></span>  <span class="italic">in writing. ‒ </span>I voted in favour of granting this discharge since I believe that the European Medicines Agency (EMA) is extremely important for the EU as a whole. I further believe that this Agency registered progress with the way it dealt with its expenditure, management of human resources and procurement procedures. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-837-625"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/97296.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Michel Dantin (PPE), </span></span>  <span class="italic">par écrit. ‒ </span>Le présent rapport propose d’accorder la décharge pour l’exercice budgétaire 2013 à l’Agence européenne des médicaments. En charge d'évaluer, coordonner et superviser le développement des nouveaux médicaments à usage humain et vétérinaire dans l’Union européenne, l’agence a reçu pour l’année 2013 une contribution de 251,56 millions d’euros. Elle dispose d’après la Cour des comptes européenne d’un taux d’exécution budgétaire satisfaisants à hauteur de 96,76 % en crédits d’engagement et de 83,49 % en crédit de paiement. Considérant que l'audit annuel de la Cour des comptes n'a relevé aucun problème notable dans l'exécution du budget, j’ai voté en faveur de la décharge. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-837-750"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96826.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Tamás Deutsch (PPE), </span></span>  <span class="italic">írásban. ‒ </span>Az Európai Számvevőszék 2013-as pénzügyi évre vonatkozó éves jelentésének bemutatását követően a 2013. évi zárszámadási eljárás keretében az Európai Parlament Költségvetési Ellenőrző Bizottsága elvégezte az Európai Unió általános költségvetésének az Európai Gyógyszerügynökségre vonatkozó pénzügyi ellenőrzését. A Számvevőszék megállapította, hogy az Európai Gyógyszerügynökség 2013-as pénzügyi évre vonatkozó éves beszámolója megbízható, és hogy az annak alapjául szolgáló ügyletek jogszerűek és szabályszerűek voltak. Felhívja az ügynökség figyelmét, hogy a felvételi eljárások során elengedhetetlen a teljes átláthatóság biztosítása. A jelentés felszólítja az ügynökséget, hogy állítson össze egy listát a zon betegszervezetekről melyekkel együttműködést folytatnak és ezt az átláthatóság érdekében tegye nyilvánossá. A zárszámadási jelentés megállapítja, hogy a pénzügyi átvilágítás rendben lezajlott és a vizsgálat során nagyobb hiányosságokat nem tapasztaltak. A szakbizottság március végi ülésén a mentesítés megadásáról, a 2013-as számlák lezárásáról döntött. A szakbizottsági szavazáson és a plenáris szavazáson is a mentesítés megadását támogattam.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-837-875"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124750.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Mireille D'Ornano (NI), </span></span>  <span class="italic">par écrit. ‒ </span>Le budget définitif de l'Agence européenne des médicaments pour l'exercice 2013 était de 251 560 000 EUR, soit une hausse de 13,07 % par rapport à 2012. La cour fait observer que 83 % du budget de l'Agence provient des redevances versées par les entreprises du secteur, ce qui représente une augmentation progressive.</p>
<p class="contents">Il n'y a d'ailleurs pas de transparence totale sur cet aspect du budget, il faudrait donc impérativement améliorer ce point afin d'éviter tout risque pour les droits des consommateurs ou la réputation de l'Agence.</p>
<p class="contents">J'ai préféré m'abstenir sur cette décharge. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-837-937"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/125071.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Γεώργιος Επιτήδειος (NI), </span></span>  <span class="italic">γραπτώς. ‒ </span>Καταψηφίζω διότι ο Οργανισμός με ορισμένες από τις δράσεις του ενδέχεται να εξυπηρετεί εμπορικά συμφέροντα και επιθυμούμε επιπλέον εξηγήσεις επί του θέματος.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-838-000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124711.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Norbert Erdős (PPE), </span></span>  <span class="italic">írásban. ‒ </span>Az Európai Néppárt irányvonalának megfelelően szavazatommal támogattam a költségvetési mentesítés megadását az Európai Gyógyszerügynökség vonatkozásában.</p>
<p class="contents">Kiemelten fontos, hogy az Európai Gyógyszerügynökség felelősen gazdálkodjon ezekkel forrásokkal. Ezért az Európai Számvevőszék esetleges észrevételeit és javaslatait az Európai Gyógyszerügynökségnek kellően figyelembe kell vennie.</p>
<p class="contents">Érdekünk, hogy az uniós intézmények a rájuk bízott forrásokkal felelősen gazdálkodjanak. Nekik kell példát mutatniuk az uniós tagállamoknak a felelős költségvetési gazdálkodás terén.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-838-125"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/4550.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Jill Evans (Verts/ALE),</span></span>   <span class="italic">in writing</span><span class="bold">. –</span> I voted in favour of this Discharge. It is important that the European Union is transparent and that my constituents in Wales can be confident that scrutiny is effective and that resources are being used properly.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-838-250"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/125101.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">José Inácio Faria (ALDE), </span></span>  <span class="italic">por escrito. ‒ </span>Tratando-se de matéria de natureza orçamental respeitante à execução do orçamento afeto a instituições e agências europeias para 2013, e tomando em consideração o relatório anual do Tribunal de Contas que assegura a fiabilidade, legalidade e regularidade das contas, bem como outras disposições legais inscritas nos recitais da proposta de decisão, votei a favor da quitação pela execução do orçamento da Agência Europeia de Medicamentos (EMA) para o exercício de 2013. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-838-500"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96899.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">José Manuel Fernandes (PPE), </span></span>  <span class="italic">por escrito. ‒ </span>O exercício de 2013 foi de 251 560 000 EUR, o que representa um aumento de 13,07 % face a 2012 contribuindo a União para o orçamento da Agência com 40 937 951 EUR (17,03 %), o que representa uma diminuição de 3,54 % face a 2012. A taxa de execução orçamental foi de 96,76% e a taxa de execução das dotações para pagamentos de 83,49%.</p>
<p class="contents">83 % do orçamento da Agência provém de taxas pagas pela indústria, que têm aumentado de forma progressiva sendo importante assegurar absoluta transparência em relação a este aspeto do orçamento para evitar pôr em causa os direitos dos consumidores ou a reputação da Agência. Os critérios de transparência para parceiros e organizações de doentes, profissionais da saúde e consumidores foram revistos, no intuito de aumentar a transparência dos financiamentos.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-839-000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/23868.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Monika Flašíková Beňová (S&amp;D), </span></span>  <span class="italic">písomne ‒ </span>Ide o technickú správu bez politického kontextu. Ide o úpravu rozpočtu pre Európsku agentúru pre lieky.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-840-000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/125070.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Λάμπρος Φουντούλης (</span></span>  <span class="bold">NI</span><span class="bold">), </span><span class="italic">γραπτώς. ‒ </span>Καταψηφίζω την έκθεση σχετικά με την απαλλαγή όσον αφορά την εκτέλεση του προϋπολογισμού του Ευρωπαϊκού Οργανισμού Φαρμάκων για το οικονομικό έτος 2013, διότι θεωρώ ότι ο Οργανισμός, με ορισμένες από τις δράσεις του, ενδέχεται να εξυπηρετεί εμπορικά συμφέροντα. Επιθυμώ να λάβω επιπλέον εξηγήσεις επί του θέματος.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-840-004"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124790.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Doru-Claudian Frunzulică (S&amp;D), </span></span>  <span class="italic">in writing. ‒ </span>The European Medicines Agency has vital importance in terms of delivering the goals and results of EU policies on the matter. This is of clear benefit to EU citizens and their performance is improving year on year. I therefore supported the grant of the discharge in respect of the implementation of the budget for the financial year 2013.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-840-003"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/102886.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Ildikó Gáll-Pelcz (PPE), </span></span>  <span class="italic">írásban. ‒ </span>Az Európai Számvevőszék elkészítette a 2013-as pénzügyi évre vonatkozó éves jelentését, melyet ismertetett az Európai Parlament plénuma előtt, majd a Költségvetési Ellenőrző Bizottságban is. A jelentés bemutatását követően a 2013. évi zárszámadási eljárás keretében az Európai Parlament Költségvetési Ellenőrző Bizottsága elvégezte az Európai Unió általános költségvetésének az ügynökségek és hivatalok költségvetése végrehajtására vonatkozó pénzügyi ellenőrzését. A szakbizottság elsődleges feladata a közösségi költségvetés végrehajtásának szabályosságát és hatékonyságát biztosítani, ellenőrizni. Az Európai Unió ügynökségeinek, hivatalainak 2012-es gazdálkodásával kapcsolatban a horizontális zárszámadási jelentés megállapítja, hogy a pénzügyi átvilágítás rendben lezajlott, és a vizsgálat során hiányosságokat nem tapasztaltak. A problémák, melyeket a jelentés kiemel, és melyekre az ügynökségeknek megoldást kell találniuk, a közbeszerzési eljárások átláthatóságának erősítése, az összeférhetetlenségi ügyekkel kapcsolatos hatékonyabb eljárás, valamint a belső ellenőrzési rendszerek további erősítése. A CONT szakbizottság márciusi ülésén a jelentés elfogadásáról, e hatóság 2013-as számláinak lezárásáról döntött. A szakbizottsági szavazáson és az április 29-ei plenáris szavazáson is a jelentés elfogadását támogattam.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-840-002"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/58758.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Elisabetta Gardini (PPE), </span></span>  <span class="italic">per iscritto. ‒ </span>Ho approvato il discarico e tutte le osservazioni contenute, ma vorrei sottolineare come su questa tematica serva un maggior coordinamento a livello europeo, specialmente per ciò che riguarda la frammentazione tra i singoli stati membri di diverse valutazioni costi/benefici dei farmaci, in particolare quelli legati alla lotta contro il cancro. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-840-001"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124817.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Enrico Gasbarra (S&amp;D),</span></span>   <span class="italic">per iscritto</span><span class="bold">. –</span> Dichiaro il mio voto favorevole alla dichiarazione del collega Ryszard Czarnecki, già approvata dalla Commissione per il Controllo dei Bilanci, in merito alla Relazione sul discarico per l'esecuzione del bilancio dell'Agenzia europea per i medicinali (EMA). Il suo compito principale è di tutelare la sanità pubblica e la salute degli animali: una missione decisiva per le sfide sociali di oggi, un'azione continua e notevole volta alla valutazione e controllo dei medicinali, sia per uso umano che veterinario. Attestiamo con questo voto una corretta ed efficiente gestione dell'agenzia, mi rallegro con il collega per il lavoro attento di verifica effettuato.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-840-500"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/4533.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Neena Gill (S&amp;D), </span></span>  <span class="italic">in writing. ‒ </span>President, I voted in favour of this report. I am pleased that the EU agencies have made demonstrable progress in implementing the "Roadmap" following the ‘Common Approach’ agreed in 2012 and that the reports demonstrate that all but one of these agencies, the EIT, can be granted immediate discharge for 2013.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-841-000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96956.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Julie Girling (ECR), </span></span>  <span class="italic">in writing. ‒ </span>I am often hesitant to grant discharge for any part of the EU budget until the budget as a whole receives a positive statement of assurance from the Court of Auditors. However, having worked closely with EMA as a member of the ENVI Committee, I am satisfied with the EMA budget and am happy to grant discharge.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-841-015"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/21331.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Sylvie Goddyn (NI), </span></span>  <span class="italic">par écrit. ‒ </span>J'ai voté contre la décharge sur l'exécution du budget de l'Agence européenne des médicaments pour l'exercice 2013.</p>
<p class="contents">Je remarque notamment que l'auditeur interne a constaté que certaines procédures ne pouvaient être vérifiées, en raison d'une absence ou d'une insuffisance de contrôles.</p>
<p class="contents">Je note aussi que 83 % du budget de l'Agence provient des redevances versées par les entreprises du secteur, ce qui fait courir à cette agence des risques importants de conflits d'intérêts.</p>
<p class="contents">Ces conflits d'intérêts sont avérés par le rapport budgétaire à propose de la définition large que cette agence donne aux "informations confidentielles à caractère commercial". Cette définition large dénote pour le moins une volonté de protéger les intérêts des entreprises concernées au détriment de la nécessaire circulation des informations.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-841-031"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124961.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Theresa Griffin (S&amp;D), </span></span>  <span class="italic">in writing. ‒ </span>I voted in favour of granting this discharge since the European Medicines Agency (EMA) is achieving good results in its area of work.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-841-062"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124763.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Antanas Guoga (ALDE), </span></span>  <span class="italic">raštu. ‒ </span>Balsavau už sprendimą patvirtinti Europos vaistų agentūros 2013 m. biudžeto įvykdymo. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-841-125"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124754.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Ivan Jakovčić (ALDE), </span></span>  <span class="italic">napisan. ‒ </span>Glasao sam ZA izvješće o razrješnici za izvršenje proračuna Europske agencije za lijekove za financijsku godinu 2013. jer se time omogućava nastavak rada Agencije koja je pokazala da slijedi načelo anuiteta i na vrijeme izvršava svoj proračun. Potrebne su međutim dodatne mjere kojima bi se jamčila transparentnost i jasnoća pri zapošljavanju, ali i u okviru drugih procesa. Važnost promicanja javnog zdravlja i zdravlja životinja, čemu Agencija teži, mora biti u skladu s financijskim i proračunskim upravljanjem kako bi učinak rada bio upečatljiv i djelotvoran. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-841-187"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124770.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Jean-François Jalkh (NI), </span></span>  <span class="italic">par écrit. ‒ </span>Le budget définitif de l'Agence européenne des médicaments pour l'exercice 2013 était de 251 560 000 EUR, soit une hausse de 13,07 % par rapport à 2012. La cour fait observer que 83 % du budget de l'Agence provient des redevances versées par les entreprises du secteur, ce qui représente une augmentation progressive.</p>
<p class="contents">Il n'y a d'ailleurs pas de transparence totale sur cet aspect du budget, il faudrait donc impérativement améliorer ce point afin d'éviter tout risque pour les droits des consommateurs ou la réputation de l'Agence.</p>
<p class="contents">J'ai préféré m'abstenir sur cette décharge. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-841-202"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124728.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Marc Joulaud (PPE), </span></span>  <span class="italic">par écrit. ‒ </span>J'ai voté en faveur de la décharge 2013 d'EMA, qui valide l'utilisation des ressources allouées par l'Union et les efforts effectués pour corriger les manques constatés par la Cour des Comptes européenne lors des exercices précédents.</p>
<p class="contents">La décharge a été accordée à une large majorité, ce dont je me félicite.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-841-218"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96884.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Philippe Juvin (PPE), </span></span>  <span class="italic">par écrit. ‒ </span>J’ai voté en faveur de ce rapport qui octroie la décharge au directeur exécutif de l’Agence européenne des médicaments (EMA) sur l’exécution du budget pour l'exercice 2013.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-841-234"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/125024.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Barbara Kappel (NI), </span></span>  <span class="italic">schriftlich. ‒ </span>Ich lehne eine Entlastung dieser Agentur aufgrund der Kostenexplosionen, einem überbordenden Personalstand und Doppelgleisigkeiten, die sich aufgrund der Tätigkeit ähnlicher Behörden auf der Ebene der Mitgliedstaaten ergeben, ab. Die Entschließung benennt diese Probleme klar, weshalb ich für sie stimme.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-841-250"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124962.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Afzal Khan (S&amp;D), </span></span>  <span class="italic">in writing. ‒ </span>I am pleased that the EU agency have made demonstrable progress made in implementing the "Roadmap" following the ‘Common Approach’ agreed in 2012 and that the report demonstrates that the agency can be granted immediate discharge for 2013. I voted therefore in favour.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-841-375"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96816.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Giovanni La Via (PPE),</span></span>   <span class="italic">per iscritto</span><span class="bold">. –</span> Signor Presidente, onorevoli colleghi, ho espresso il mio voto a favore per l´approvazione del discarico dell´Agenzia europea per i medicinali, di cui riconosce la cruciale importanza per la salvaguardia della salute umana e della prevenzione medica nonché per l'attività di ricerca scientifica. Infatti si riconosce che l'audit annuale della Corte dei conti non ha rilevato nulla di particolare per quanto riguarda il livello dei riporti nel 2013 e in generale per l'esecuzione del bilancio.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-841-390"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/125047.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Paloma López Bermejo (GUE/NGL), </span></span>  <span class="italic">por escrito. ‒ </span>Según los Tratados, el Parlamento Europeo tiene el derecho de escrutinio sobre la legalidad y la regularidad de la ejecución de los gastos de las instituciones y agencias europeas cada año. El principal objetivo del ejercicio de este derecho es el de asegurar que los fondos públicos se utilizan de la mejor manera posible. Este escrutinio se basa en el informe del Tribunal de cuentas Europeo, en un procedimiento escrito de preguntas y respuestas, y por último en las audiencias públicas de las instituciones y agencias frente el Parlamento Europeo.</p>
<p class="contents">El Parlamento no ha detectado ninguna irregularidad en la ejecución del presupuesto de la Agencia Europea de Medicamentos (EMA), por eso he votado a favor de aprobar la gestión del mismo.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-841-406"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96824.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Monica Macovei (PPE), </span></span>  <span class="italic">in writing. ‒ </span>I fully endorse the decision of European Parliament to grant the discharge to the European Medicines Agency for the year 2013.</p>
<p class="contents">The Agency’s budget implementation rates for the year 2012 were satisfactory. The rate of appropriations carried over was high (27 %), but this was due primarily to the Agency’s move to a new location which took place in 2014. The comprehensive conflict of interest policy put into place is an example for other agencies. Despite this, there is still place for improvement. The Selection Board members did not always complete their conflict of interest declarations, or did not do so in a timely manner, and there was no evidence of action taken to address the issues raised by these declarations. The documentation of the Selection Board’s proceedings was not always adequate and there is no evidence as to how the method for the short-listing of candidates was established and that the questions for the written tests or interviews were set before the examinations, but all in all, the Medicine Agency performed well.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-841-413"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/119436.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Ivana Maletić (PPE), </span></span>  <span class="italic">napisan. ‒ </span>Zdravlje nam je sve ugroženije, a bolesti sve češće zbog načina na koji danas živimo. Farmaceutska industrija je snažna i svakodnevno se otkrivaju novi lijekovi koje je važno provjeravati i kontrolirati. Glavna svrha Europske agencije za lijekove je zaštita i unapređenje zdravlja ljudi i životinja kontrolom lijekova koji se koriste u medicinske i veterinarske svrhe. </p>
<p class="contents">Revizorski sud je potvrdio pouzdanost računovodstvene dokumentacije Europske agencije za lijekove i zakonitosti i pravilnosti osnovnih transakcija. Konačni proračun Agencije za financijsku godinu 2013. iznosio je 251 milijun eura, od čega je Unija doprinijela 40,9 milijuna eura.</p>
<p class="contents">Podržala sam razrješnicu Europskog parlamenta o zaključavanju poslovnih knjiga Agencije za 2013. Obzirom na veličinu i snagu farmaceutske industrije i njenog utjecaja na kupovne preferencije ljudi važno je da Agencija ima strogu politiku sprječavanja sukoba interesa i transparentnosti. Europski parlament pozdravlja usvajanje standarda unutarnje kontrole u svrhu dosljednosti nad svima aktivnostima Agencije.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-841-421"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/125069.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Νότης Μαριάς (ECR), </span></span>  <span class="italic">γραπτώς. ‒ </span>Για λόγους έλλειψης: α) πλήρους διαφάνειας, β) σοβαρής τεκμηρίωσης, γ) αξιοπιστίας, δ) επαρκών στοιχείων αναφορικά με την εκτέλεση του υπό ψήφιση προϋπολογισμού του οικείου Οργανισμού, καταψηφίζω την Έκθεση σχετικά με την απαλλαγή όσον αφορά την εκτέλεση του προϋπολογισμού του Ευρωπαϊκού Οργανισμού Φαρμάκων για το οικονομικό έτος 2013. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-841-437"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124751.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Dominique Martin (NI),</span></span>   <span class="italic">par écrit</span><span class="bold">. –</span> Je me suis abstenu sur ce vote. Même si le rapport ne souligne aucune erreur majeure un manque de transparence sur certains aspects du budget est tout de même mentionné. Dans le doute je me suis donc abstenu.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-841-500"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124828.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Fulvio Martusciello (PPE), </span></span>  <span class="italic">per iscritto. ‒ </span>La relazione sul discarico 2013 per l'esecuzione del bilancio dell'Agenzia europea per i medicinali (EMA), valuta le questioni relative alle prestazioni, alla gestione finanziaria e al controllo dell'Agenzia UE. Ho espresso il mio parere favorevole, in linea con il mio gruppo politico, in quanto ho ritenuto positive le indagini di controllo e valutazione sui costi dell´ Agenzia europea per i medicinali (EMA). Nello specifico c'è da sottolineare come tutte le agenzie dell'UE debbano rispettare il principio dell'annualità come scadenza per la presentazione del loro bilancio. Inoltre, considerando la loro interconnessione ci aspettiamo una collaborazione sempre maggiore tra questa e le altre Agenzie con la sottoscrizione di protocolli d'intesa che permettano una migliore gestione dei bilanci e criteri di trasparenza della spesa. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-841-562"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/38511.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Georg Mayer (NI), </span></span>  <span class="italic">schriftlich. ‒ </span>Dieser äußerst kritischen Resolution habe ich zugestimmt.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-841-625"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96742.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Jean-Luc Mélenchon (GUE/NGL), </span></span>  <span class="italic">par écrit. ‒ </span>Le pouvoir de décharge budgétaire du Parlement devrait lui permettre de faire respecter par l'ensemble des institutions et agences européennes les engagements budgétaires pris. Or la Commission comme le Conseil ne tiennent quasiment aucun compte des votes du Parlement, y compris quand il refuse la décharge. C'est un symptôme de l'impuissance démocratique du Parlement dans l'UE. Le budget 2013 ayant encore une fois été exécuté de manière particulièrement chaotique, toute décharge donnée pour cet exercice pose problème. En effet, cette année-là, la Commission et le Conseil ont réussi à mettre en réserve et reporter 1 milliard d'excédents alors que l'UE avait accumulé 20 milliards d'impayés. Cette application sauvage de l'austérité est inadmissible et absurde. Le budget l'Agence européenne des médicaments (EMA) n'étant qu'une composante du budget européen 2013 auquel je me suis opposé, je vote contre la décharge sur ce budget.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-841-750"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/118859.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Roberta Metsola (PPE), </span></span>  <span class="italic">in writing. ‒ </span>Following the recommendation from the Council, the declaration of assurance from the Court of Auditors and the report from the Committee of Budgetary Control, I chose to support the decision regarding the discharge on implementation of the budget of the European Medicines Agency for the financial year 2013.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-842-000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/118858.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Marlene Mizzi (S&amp;D), </span></span>  <span class="italic">in writing. ‒ </span>I voted in favour of the report on discharge in respect of the implementation of the budget of the European Medicines Agency for the financial year 2013.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-842-006"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124769.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Sophie Montel (NI),</span></span>   <span class="italic">par écrit</span><span class="bold">. –</span> Le rapport sur l’Agence européenne des médicaments mentionne un budget pour 2013 de 251,56 millions d’euros, ce qui correspond à une hausse de 13,07% par rapport à 2012, dont 40,938 millions d’euros proviennent du budget de l’UE. Bien qu’on puisse déplorer un manque de transparence sur certains aspects, on peut saluer le fait que plus de 80% de son budget proviennent de redevances versées par les entreprises du secteur. Pour ces raisons, je me suis abstenue lors de ce vote.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-842-007"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/72779.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Nadine Morano (PPE), </span></span>  <span class="italic">par écrit. ‒ </span>J'ai voté en faveur de ce texte relatif à la décharge budgétaire 2013 pour l'Agence européenne des médicaments, qui joue un rôle essentiel dans la protection et la promotion de la santé publique et animale. La décharge est accordée, le budget ayant été exécuté sans erreur significative. La décharge budgétaire, qui peut être accordée, ajournée ou refusée par le Parlement européen, constitue le contrôle final du budget annuel. Le processus de décharge représente le volet politique du contrôle de l’exécution budgétaire. Il prend appui sur les rapports de la Cour des Comptes et sur les précisions apportées par les organismes concernés. La décision de décharge peut s’accompagner de recommandations pour améliorer certains aspects de l’exécution budgétaire.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-842-004"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/38596.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Elisabeth Morin-Chartier (PPE), </span></span>  <span class="italic">par écrit. ‒ </span>J'ai voté en faveur de la décharge budgétaire de l'Agence européenne des médicaments (EMA), procédure qui permet aux députés de valider l'implémentation du budget de cette agence. En effet, l'Agence européenne des médicaments a su prouver sa bonne gestion financière et tenir compte des recommandations ultérieures, il doit poursuivre ses efforts dans les domaines qui peuvent être améliorés.</p>
<p class="contents">L'adoption de ce texte entraîne la clôture de l'exercice budgétaire de l'Union européenne de l'année 2013. Cette procédure est nécessaire au bon fonctionnement des institutions européennes et assure la transparence, devant les citoyens de l’Union, de la gestion des fonds qui leur sont confiés. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-842-005"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/28429.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Alessandra Mussolini (PPE), </span></span>  <span class="italic">per iscritto. ‒ </span>Considerando che la Corte dei conti, nella sua relazione sul bilancio annuale dell’Agenzia europea per i medicinali (EMA) per l'esercizio 2013, ha dichiarato di aver ottenuto ragionevoli garanzie in merito all'affidabilità dei conti nonché alla legittimità e alla regolarità delle operazioni sottostanti, ho deciso di sostenere la richiesta del relatore Czarnecki di concedere il discarico.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-842-003"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/88882.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Victor Negrescu (S&amp;D), </span></span>  <span class="italic">în scris. ‒ </span>Bugetul anual al Uniunii Europene se ridică la 145 de miliarde de euro (conform cifrelor din 2015). Această sumă nu reprezintă decât 1% din veniturile generate anual de economiile UE, deși este o sumă importantă. Fiecare buget anual face parte dintr-un ciclu bugetar de șapte ani cunoscut sub numele de „perspectivă financiară”. Perspectivele financiare sunt stabilite de Comisia Europeană și necesită aprobarea în unanimitate din partea statelor membre și negocieri care să fie urmate de acordul Parlamentului European. După stabilirea bugetului pentru exercițiul bugetar din anul următor, întotdeauna în anul care urmează celui în care s-a consumat bugetul prevăzut cu un an înainte, se realizează descărcarea bugetară pentru urmărirea și veficarea utilizării corecte a fondurilor așa cum au fost prevăzute pentru fiecare instituție, organism, domeniu, în parte. Am votat această propunere de rezoluție referitoare la descărcarea de gestiune pentru execuția bugetului Agenției Europene pentru Medicamente aferent exercițiului financiar 2013, având în vedere importanța majoră pe care o reprezintă informarea cetățenilor UE, în ceea ce privește utilizarea bugetului UE, buget la care contribuie și aceștia implicit.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-842-008"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96981.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Franz Obermayr (NI), </span></span>  <span class="italic">schriftlich. ‒ </span>Prinzipiell stehe ich der Europäischen Arzneimittel Agentur nicht ablehnend gegenüber und sehe, dass sie von einem gewissen Nutzen für das Gesundheitswesen der Mitgliedsstaaten ist. Dennoch kann ich aus erheblichen Bedenken aufgrund der Ausgabenpraxis der Agentur keine Zustimmung zu der Entlastung gewähren.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-842-009"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/129073.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Urmas Paet (ALDE), </span></span>  <span class="italic">kirjalikult. ‒ </span>Andsin heakskiidu 2013. aasta eelarve täitmisele, mis kinnitab 2013. aasta raamatupidamise aastaaruande usaldusväärsust ja selle aluseks olevate tehingute seaduslikkust ja korrektsust. Amet täidab väga tähtsat rolli inim- ja veterinaarravimite hindamise ja järelevalve kaudu inimeste ja loomade tervise kaitsmisel ja edendamisel. Seega nad võiksid veelgi täiustada oma huvide konfliktide haldamise ja käsitlemise tegevuskava, et tagada kõigis ameti tegevusvaldkondades sõltumatus ja läbipaistvus.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-842-002"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/36392.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Aldo Patriciello (PPE), </span></span>  <span class="italic">per iscritto. ‒ </span>Cari colleghi e care colleghe,</p>
<p class="contents">considerato che, stando ai suoi rendiconti finanziari, il contributo complessivo</p>
<p class="contents">dell'Unione al bilancio dell'Agenzia per il 2013 ammontava a 40 937 951 EUR (pari al</p>
<p class="contents">17,03%), importo che rappresenta una diminuzione del 3,54% rispetto al 2012; considerato che la Corte dei conti, nella sua relazione sui conti annuali dell'Agenzia europea per i medicinali relativi all'esercizio 2013, ha dichiarato di aver ottenuto garanzie ragionevoli in merito all'affidabilità dei conti annuali dell'Agenzia, nonché alla legittimità e alla regolarità delle operazioni alla base di tali conti;</p>
<p class="contents">Per tali ragioni ho espresso il mio voto favorevole</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-842-126"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124749.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Marijana Petir (PPE), </span></span>  <span class="italic">napisan. ‒ </span>Glavni zadatak Europske agencije za lijekove je zaštita i unapređenje zdravlja ljudi i životinja nadzorom nad lijekovima koji se koriste u medicinske i veterinarske svrhe. Jedna od najvažnijih aktivnosti je nadzor nad lijekovima nakon njihovog odobrenja na način da agencija prima sigurnosna izvješća iz Unije i izvan nje, te koordinira akcije koje pridonose kvaliteti i sigurnosti lijekova. </p>
<p class="contents">Agencija također ispituje certifikate medicinskih proizvoda u sklopu naputaka koje izdaje Svjetska zdravstvena organizacija. Druga je aktivnost inspekcijski nadzor nad kliničkom praksom, laboratorijskim radom, proizvodnjom i izdavanjem certifikata za medicinske proizvode, te nadzor nad kvalitetom i postupanje u slučaju da se utvrde nedostaci tih proizvoda. </p>
<p class="contents">Financijsko izvješće je pokazalo da je stopa izvršenja proračuna Agencije 96,76 %, a da su plaćena sredstva bila 83,49 %. Podržala sam razrješnicu upravo zbog potrebe rada Agencije za kontrolu sigurnosti i kvalitete lijekova prvenstveno zbog zdravlja ljudi i zdravlja životinja.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-842-188"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/110977.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Florian Philippot (NI), </span></span>  <span class="italic">par écrit. ‒ </span>Le budget définitif de l'Agence européenne des médicaments pour l'exercice 2013 était de 251 560 000 EUR, soit une hausse de 13,07 % par rapport à 2012. La Cour des comptes fait observer que 83 % du budget de l'Agence provient des redevances versées par les entreprises du secteur, ce qui représente une augmentation progressive. Il n'y a pas d'ailleurs pas de transparence totale sur cet aspect du budget. Il faudrait donc impérativement améliorer ce point afin d'éviter tout risque pour les droits des consommateurs ou la réputation de l'Agence. Dans ces conditions, je préfère m’abstenir sur le rapport.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-842-219"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/112744.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Tonino Picula (S&amp;D), </span></span>  <span class="italic">napisan. ‒ </span>Europska agencija za lijekove ima kontrolnu ulogu i zadužena je za znanstvenu procjenu lijekova koje razvijaju europske i svjetske farmaceutske kompanije, a prodaju se u Europskoj uniji. Bez autorizacije ove agencije, kompanije ne smiju izaći na europsko tržište. </p>
<p class="contents">Radi sigurnosti i zdravlja građana Unije, važno je da ova Agencija ima što transparentnije financiranje i zapošljavanje. Pozdravio bih inicijativu održavanja javnih radionica o sukobima interesa koju Agencija provodi i predlažem slične inicijative i drugim Agencijama kako bi definirale ravnotežu između nepristranosti i stručnosti djelatnika agencija.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-842-235"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/112755.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Andrej Plenković (PPE), </span></span>  <span class="italic">napisan. ‒ </span>Podržavam prijedlog odluke Europskog parlamenta o davanju razrješnice izvršnom direktoru za izvršavanje proračuna Europske agencije za lijekove za financijsku godinu 2013. </p>
<p class="contents">Uloga Agencije u zaštiti i promicanju javnog zdravlja i zdravlja životinja ocjenjivanjem i nadziranjem lijekova za humanu i veterinarsku uporabu neupitna je, a svojom jasnom politikom rješavanja sukoba interesa iz ožujka 2012. Agencija se nalazi na odličnom putu maksimalnog zajamčenja neovisnosti i transparentnosti u svim svojim područjima rada.</p>
<p class="contents">Kako su mišljenja Europskog revizorskog suda i nadležnog Odbora za okoliš javno zdravlje i sigurnost hrane potvrdila zakonitost i pravilnost financijskih upravljanja u svim značajnim aspektima, vjerujem da će donošenje ove odluke biti potvrda dobrog upravljanja i rada Agencije.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-842-251"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/108080.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Franck Proust (PPE), </span></span>  <span class="italic">par écrit. ‒ </span>Je me suis exprimé en faveur de la décharge approuvant l'exécution du budget de l'Agence européenne des médicaments et permettant ainsi la clôture des comptes pour l'exercice 2013.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-842-501"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96903.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Paulo Rangel (PPE), </span></span>  <span class="italic">por escrito. ‒ </span>Ao dar quitação a uma instituição ou agência, o Parlamento Europeu aprova a boa utilização do erário público na execução orçamental, alcançada no respeito pela regulamentação. Após recomendação do Conselho, os deputados ao Parlamento Europeu são chamados a exercer controlo sobre a gestão das dotações, decidindo sobre a quitação com base nos relatórios do Tribunal de Contas. Assim e avaliados os relatórios do Tribunal de Contas e da Comissão Parlamentar do Controlo Orçamental, votei favoravelmente a presente decisão que dá quitação ao Diretor Executivo da Agência Europeia de Medicamentos pela execução do orçamento da Agência para o exercício de 2013.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-843-000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/4253.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Frédérique Ries (ALDE), </span></span>  <span class="italic">par écrit. ‒ </span>C'est sans surprise que les députés européens ont approuvé la clôture des comptes de l'Agence européenne des médicaments pour l'exercice 2013.</p>
<p class="contents">Cette agence a été créée en 2004 dans la foulée de la réglementation établissant des procédures communautaires pour l'autorisation et la surveillance en ce qui concerne les médicaments à usage humain et à usage vétérinaire. Elle était dotée, en 2013, d'un budget important: 251 560 000 euros, dont 16,3 % (soit 40 937 454 euros) provenant de contributions budgétaires de l'Union (dont une contribution spéciale, importante et nécessaire, pour la réduction de la redevance pour les médicaments orphelins de 6 509 360 euros).</p>
<p class="contents">Il est également important de noter, comme l'a fait dans son avis la commission de l'environnement, de la santé publique et de la sécurité alimentaire, le rôle essentiel joué par l'Agence dans la protection et la promotion de la santé publique et animale.</p>
<p class="contents">Autre point à souligner: les améliorations dans la politique de gestion des conflits d'intérêts, adoptée par le conseil d'administration en mars 2012, et l'invitation faite à l'Agence de continuer à renforcer sa politique de gestion des conflits d'intérêts afin de garantir l'indépendance et la transparence de ses activités.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-843-500"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/125099.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Liliana Rodrigues (S&amp;D), </span></span>  <span class="italic">por escrito. ‒ </span>O processo de quitação orçamental é o instrumento que garante a responsabilidade e a transparência na gestão dos fundos comunitários e a supervisão do número crescente de agências europeias. Cabe ao Parlamento encerrar um “ciclo orçamental”. Isso não pode ser feito sem um rigoroso controlo orçamental, verificando se o dinheiro foi correctamente gerido e determinando exactamente as despesas e receitas de um exercício. Apesar de surgir como algo que parece excessivamente burocrático e exaustivo, este é um momento essencial para o regular e correcto funcionamento das instituições europeias. A execução do orçamento da Agência Europeia de Medicamentos não apresentou problemas relevantes.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-843-625"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/125043.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Inmaculada Rodríguez-Piñero Fernández (S&amp;D),</span></span>   <span class="italic">por escrito</span><span class="bold">. –</span> He apoyado este informe dado que el Tribunal de Cuentas ha observado cómo se han implementado mejoras respecto a observaciones realizadas en ejercicios precedentes. Hay que destacar que los esfuerzos de supervisión del presupuesto durante el ejercicio 2013 dieron lugar a un porcentaje de ejecución presupuestaria del 96,76 % mientras que la tasa de ejecución de los créditos de pago alcanzó el 83,49 %.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-843-687"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/125107.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Claude Rolin (PPE), </span></span>  <span class="italic">par écrit. ‒ </span>J'ai voté en faveur de l'octroi de la décharge au directeur exécutif de l'Agence sur l'exécution du budget de l'Agence sur l'exercice 2013. Je motive notamment ce choix du fait que la Cour des comptes avait indiqué avoir obtenu l'assurance raisonnable que les comptes annuels de l'Agence pour l'exercice 2013 étaient fiables et que les opérations sous-jacentes étaient légales et régulières. </p>
<p class="contents">A noter que le budget définitif de l'Agence pour l'exercice 2013 était de 251,56 millions EUR, soit une hausse de 13,07% par rapport à 2012 dont la part de l'Union européenne se monte à 40.937.951 EUR. Pour celles et ceux qui voudraient prendre connaissance de la série d’observations faite par les Députés sur la gestion quotidienne de l’EMA, je ne peux que trop vous conseiller de consulter le rapport en question. Vous y trouverez notamment un série d’observations sur les virements de crédits, les procédures de passation de marchés, les recrutements, les audits et contrôles internes et la prévention et gestion des conflits d'intérêts. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-843-750"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124730.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Fernando Ruas (PPE), </span></span>  <span class="italic">por escrito. ‒ </span>Estamos perante mais um dos 52 Relatórios de Quitação que votámos nesta Sessão Plenária, no âmbito das competências do Parlamento Europeu e muito concretamente das obrigações decorrentes da aplicação do disposto no artigo 94 e no Anexo V do Regimento.</p>
<p class="contents">A Agência Europeia de Medicamentos integra-se no grupo das 32 Agências descentralizadas cujas contas são alvo desta apreciação política anual por parte do Parlamento Europeu relativa ao controle orçamental do ano n-2 (no caso vertente, 2013) e no grupo das 31 Agências que viram as suas contas encerradas, pela aprovação favorável em sede de Plenário, do respectivo Relatório de Quitação efectuado pela Comissão do Controlo Orçamental, no seguimento da Declaração do Tribunal de Contas (que procedeu a uma análise cuidada e atempada das contas desta Agência) e da recomendação do Conselho.</p>
<p class="contents">À semelhança de declarações de voto anteriores sobre esta mesma matéria, termino, referenciando que esta proposta de decisão contou com o meu voto favorável e mais uma vez congratulando o Relator pelo esforço de síntese e clareza na explanação colocados na elaboração deste Relatório (e também nas outras 45 propostas de decisão sobre quitações de orçamentos das quais foi relator!).</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-843-875"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/125670.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Massimiliano Salini (PPE), </span></span>  <span class="italic">per iscritto. ‒ </span>A seguito di una valutazione positiva della commissione controllo bilanci, ho deciso di votare a favore del discarico per il bilancio 2013 dell'EMA, Agenzia europea per i medicinali. L'agenzia riveste un ruolo importante nella protezione e promozione della sanità pubblica e della salute degli animali attraverso la valutazione e la supervisione dei medicinali per uso umano e veterinario. Per questo motivo e per il fatto che la Corte dei conti, nella sua relazione sui conti annuali dell'Agenzia europea per i medicinali relativi all'esercizio 2013, ha dichiarato di aver ottenuto garanzie ragionevoli in merito all'affidabilità dei conti annuali dell'Agenzia, nonché alla legittimità e alla regolarità delle operazioni alla base di tali conti, ho votato a favore del discarico.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-843-937"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/125049.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Lidia Senra Rodríguez (GUE/NGL), </span></span>  <span class="italic">por escrito. ‒ </span>Según los Tratados, el Parlamento Europeo tiene el derecho de escrutinio sobre la legalidad y la regularidad de la ejecución de los gastos de las instituciones y agencias europeas cada año. El principal objetivo del ejercicio de este derecho es el de asegurar que los fondos públicos se utilizan de la mejor manera posible. Este escrutinio se basa en el informe del Tribunal de cuentas Europeo, en un procedimiento escrito de preguntas y respuestas, y por último en las audiencias públicas de las instituciones y agencias frente el Parlamento Europeo.</p>
<p class="contents">El Parlamento no ha detectado ninguna irregularidad en la ejecución del presupuesto de la Agencia Europea de Medicamentos (EMA), por eso he votado a favor de aprobar la gestión del mismo.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-844-000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124948.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Siôn Simon (S&amp;D), </span></span>  <span class="italic">in writing. ‒ </span>Labour MEPs voted in support of the report on discharge in respect of the implementation of the budget of the European Medicines Agency for the financial year 2013.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-844-125"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/119435.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Davor Ivo Stier (PPE), </span></span>  <span class="italic">napisan. ‒ </span>Podržavam ovo izvješće o davanju razrješnice za izvršenje proračuna Europske agencije za lijekove za financijsku godinu 2013., budući da je Revizorski sud u svojem izvješću o godišnjoj računovodstvenoj dokumentaciji Europske agencije za lijekove za financijsku godinu 2013. („izvješće Revizorskog suda”) izjavio da je stekao razumno uvjerenje da je godišnja računovodstvena dokumentacija Agencije pouzdana te da su osnovne transakcije zakonite i pravilne. </p>
<p class="contents">Iz navedenog izvješća je također vidljivo da su poduzete određene korektivne mjere u vezi s trima primjedbama koje su iznesene u izvješću Revizorskog suda za 2011. i u izvješću Revizorskog suda za 2012. nose oznake „U tijeku” ili „Predstoji” te su te primjedbe u aktualnom izvješću Revizorskog suda za 2013. označene oznakom „Dovršeno”. </p>
<p class="contents">Isto tako je pohvalna činjenica da su do kraja 2013. godine popunjena 583 od ukupno 611 radnih mjesta te da je Agencija zaposlila 144 ugovorna djelatnika. Rad navedene agencije jest zaista od iznimne važnosti upravo radi zaštite i promicanja javnog zdravlja i zdravlja životinja ocjenjivanjem i nadziranjem lijekova za humanu i veterinarsku uporabu, te mi je zadovoljstvo podržati ovo izvješće o davanju razrješnice za proračun iste.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-844-250"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/119434.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Dubravka Šuica (PPE), </span></span>  <span class="italic">napisan. ‒ </span>Glasovala sam za izvješće o razrješnici za izvršenje proračuna Europske agencije za lijekove za financijsku godinu 2013. budući da Agencija koordinira znanstvene resurse koje su na raspolaganje stavila nacionalna tijela kako bi se zajamčili provjera i nadzor lijekova koji se koriste za liječenje životinja i ljudi.</p>
<p class="contents">Važna uloga Agencije je zaštita i promicanje javnog zdravlja i zdravlja životinja ocjenjivanjem i nadziranjem lijekova za humanu i veterinarsku uporabu. Kako bi poboljšala komunikaciju s građanima Unije, Agencija je nedavno provela nekoliko inicijativa, a ističe se i razvoj informatičkih alata za komunikaciju kao što je „Komunikacija o javnom zdravlju” kojom se javnosti daju ključne informacije o lijekovima, a posebice o njihovoj sigurnosti. Odobrena sredstva u početnom proračunu Europske agencije za lijekove za 2013. povećana su za 4,08 % u odnosu na početni proračun za 2012.</p>
<p class="contents">2013. je došlo do izmjene proračuna da bi se uzelo u obzir povećanje prihoda, te je ukupni proračun povećan za 13,1 % u odnosu na konačni proračun za 2012. Odgovarajući rashodi dodijeljeni su za projekt opremanja novog sjedišta Agencije koje je u tijeku.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-844-500"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/125072.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Ελευθέριος Συναδινός (</span></span>  <span class="bold">NI</span><span class="bold">), </span><span class="italic">γραπτώς. ‒ </span>Όσον αφορά την εκτέλεση του γενικού προϋπολογισμού της Ευρωπαϊκής Ένωσης για το οικονομικό έτος 2013, οι πληροφορίες που παρέχονται σχετικά με τα οικονομικά μεγέθη δεν δικαιολογούν την απαλλαγή του Ευρωπαϊκού Οργανισμού Φαρμάκων.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-845-000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/29579.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Marc Tarabella (S&amp;D), </span></span>  <span class="italic">par écrit. ‒ </span>J'ai voté en faveur de cette décharge du budget pour 2013. Notre groupe politique a déposé nombre d'amendements qui ont fait l'objet de plusieurs débats en interne les semaines qui ont précédé la plénière. Les socialistes européens se sont prononcés positivement. La proposition a été votée à la majorité ce mercredi.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-845-500"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/125032.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Ramón Luis Valcárcel Siso (PPE), </span></span>  <span class="italic">por escrito. ‒ </span>Mediante este informe el Parlamento aprueba la gestión de la institución para el ejercicio 2013 y presenta sus observaciones en la resolución que figura a continuación del informe. Por ello es coherente aprobar este informe.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-845-750"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/125050.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Ángela Vallina (GUE/NGL), </span></span>  <span class="italic">por escrito. ‒ </span>Según los Tratados, el Parlamento Europeo tiene el derecho de escrutinio sobre la legalidad y la regularidad de la ejecución de los gastos de las instituciones y agencias europeas cada año. El principal objetivo del ejercicio de este derecho es el de asegurar que los fondos públicos se utilizan de la mejor manera posible. Este escrutinio se basa en el informe del Tribunal de cuentas Europeo, en un procedimiento escrito de preguntas y respuestas, y por último en las audiencias públicas de las instituciones y agencias frente el parlamento Europeo.</p>
<p class="contents">El Parlamento no ha detectado ninguna irregularidad en la ejecución del presupuesto de la Agencia Europea de Medicamentos (EMA), por eso he votado a favor de aprobar la gestión del mismo.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-846-000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/125100.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Miguel Viegas (GUE/NGL), </span></span>  <span class="italic">por escrito. ‒ </span>Estamos aqui a tratar de um processo formal através do qual se reconhece que a execução orçamental do organismo objeto de análise está de acordo com o que foi previamente orçamentado. Trata-se, portanto, de avaliar a validade contabilística de um documento. Deste ponto de vista pouco temos a comentar.</p>
<p class="contents">Já quanto aos considerandos políticos subjacentes ao papel desta instituição no quadro de um processo de integração baseado em valores que não partilhamos, não podemos deixar de vincar o nosso ponto de vista profundamente crítico. Este processo de integração, do qual este organismo ou instituição é parte integrante, representa hoje um fator de enorme retrocesso social e um fator que acentua as desigualdades económicas, sociais e territoriais.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-846-500"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/125001.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Harald Vilimsky (NI), </span></span>  <span class="italic">schriftlich. ‒ </span>Dieser äußerst kritischen Resolution habe ich zugestimmt.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-846-625"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124825.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Beatrix von Storch (ECR), </span></span>  <span class="italic">schriftlich. ‒ </span>Die Agenturitis der EU muss beendet werden. Deswegen lehne ich Haushalts-Entlastung der Agenturen grundsätzlich ab. Auch die der Europäischen Arzneimittelagentur. Niemand kann ihren "europäischen Mehrwert" konsequent nachweisen. Ausserdem gibt es seit 50 Jahren bereits eine für alle EU-Mitgliedsstaatn verbindliche "Europäische Direktion für Arnbzimittelsicherheit" (EDQM, European Pharmacopoeia) beim Europarat. Wozu also die geldverschwendende Doppelstruktur? </p>
<p class="contents">Agenturen sind meist aus der EU-Kommission ausgegliederte Direktionen, die zu einer juristisch eigenständigen Behörde umformiert werden. Eingespart wird dadurch gar nichts. Agenturen entstehen meist aufgrund der Kompromiss-Kuhhandel zwischen den Staats- und Regierungschefs auf dem Brüsseler Basar. Man muss nur ein Problem finden, um eine Agentur irgendwie zu begründen. Einmal eingerichtet, wird man sie nicht mehr los, weil die Regierungen ihre Pfründe sichern. Nun gibt es mehr als 40 Agenturen in 4 Kategorien: dezentrale Agenturen, Exekutivagenturen, EURATOM-Agenturen und das Europäische Innovations- und Technologieinstitut (EIT). Die größte Ironie der "Agenturitis" ist, dass die ausgelagerten Behörden oftmals geographisch so weit von der Zentrale der EU-Kommission entfernt sind, dass eine effiziente Zusammenarbeit und Kontrolle im Tagesgeschäft nicht möglich ist. Also eröffnen die Agenturen eigene Verbindungsbüros in Brüssel. Damit lösen sich die Einsparungsvorschläge der EU-Kommission von selbst auf. Da ich mich jedoch für eine schlanke EU-Verwaltung einsetze, kann ich der Entlastung der Agentur nicht zustimmen.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="3-846-750"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96933.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Milan Zver (PPE), </span></span>  <span class="italic">pisno. ‒ </span>Za poročilo o razrešnici glede izvrševanja proračuna Evropske agencije za zdravila za proračunsko leto 2013 sem glasoval, ker je Računsko sodišče v poročilu o zaključnem računu agencije za proračunsko leto 2013 navedlo, da je prejelo razumno zagotovilo o zanesljivosti letnih računovodskih izkazov agencije ter o zakonitosti in pravilnosti z njim povezanih transakcij. Agencija sicer deluje prek mreže in usklajuje znanstvene vire, ki jih a razpolago ponudijo nacionalni organi, tako da zagotovi vrednotenje in nadzor zdravil za humano in veterinarsko uporabo. Poročilo v nadaljevanju tudi poudarja, da ima agencija pomembno vlogo pri varovanju in spodbujanju javnega zdravja in zdravja živali z ocenjevanjem in nadzorovanjem zdravil za humano ali veterinarsko uporabo.</p></td><td width="16"> </td></tr></table></td></tr></table><table width="100%" border="0" cellspacing="0" cellpadding="5"><tr class="footerdocwin"><td></td><td align="right"><a target="_blank" href="/legal-notice/en">Legal notice</a> - <a target="_blank" href="/privacy-policy/en">Privacy policy</a></td></tr></table></td></tr></table></body></html>
